Sale!

ALG12 Gene Glycosylation Disorder Type 1G Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The ALG12 Gene Glycosylation Disorder Type 1G Genetic Test is a specialized diagnostic tool available at DNA Labs UAE, aimed at identifying mutations in the ALG12 gene, which can lead to Congenital Disorders of Glycosylation (CDG). Type 1G CDG, specifically caused by mutations in the ALG12 gene, is a rare genetic condition that affects the body’s ability to properly glycosylate proteins and lipids, integral processes for normal cellular functions. Symptoms of the disorder can vary widely among individuals but may include developmental delay, intellectual disability, and various other systemic complications.

Priced at 4400 AED, the test involves analyzing the patient’s DNA to detect any mutations in the ALG12 gene, providing crucial information for accurate diagnosis and management of the condition. Conducted at DNA Labs UAE, a leading facility in genetic testing, the procedure ensures high accuracy and reliability, offering essential insights for affected individuals and their families. This genetic test is a vital resource for clinicians in developing personalized treatment plans and for families seeking to understand the genetic basis of the disorder, potentially guiding decisions regarding family planning.

Description

ALG12 Gene Glycosylation disorder type 1G Genetic Test

Components: ALG12 gene glycosylation disorder type 1G genetic test

Price: 4400.0 AED

Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card

Report Delivery: 3 to 4 Weeks

Method: NGS Technology

Test type: Metabolic Disorders

Doctor: General Physician

Test Department: Genetics

Pre Test Information: Clinical History of Patient who is going for ALG12 Gene Glycosylation disorder type 1G NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with Glycosylation disorder type 1G.

Test Details: ALG12 gene glycosylation disorder type 1G is a rare genetic disorder that affects the glycosylation process in the body. Glycosylation is the process by which sugar molecules are attached to proteins and lipids, forming glycoproteins and glycolipids. This process is important for the proper functioning of many proteins in the body.

The ALG12 gene provides instructions for making an enzyme called dolichyl-P-Man:Man(7)GlcNAc(2)-PP-dolichol-alpha-1,6-mannosyltransferase. This enzyme is involved in the glycosylation process, specifically the addition of mannose sugars to glycoproteins. Mutations in the ALG12 gene can disrupt the glycosylation process, leading to glycosylation disorder type 1G.

This disorder can result in a wide range of symptoms, including developmental delay, intellectual disability, seizures, facial dysmorphism, and other physical abnormalities.

NGS (Next-Generation Sequencing) genetic testing is a type of genetic test that uses advanced sequencing technologies to analyze multiple genes simultaneously. In the case of ALG12 gene glycosylation disorder type 1G, NGS genetic testing can be used to identify mutations or variations in the ALG12 gene that may be responsible for the disorder.

By identifying these genetic variations, NGS genetic testing can provide a definitive diagnosis for individuals with suspected ALG12 gene glycosylation disorder type 1G. This can help guide medical management and treatment options for affected individuals and their families.

Test Name	ALG12 Gene Glycosylation disorder type 1G Genetic Test
Components
Price	4400.0 AED
Sample Condition	Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery	3 to 4 Weeks
Method	NGS Technology
Test type	Metabolic Disorders
Doctor	General Physician
Test Department:	Genetics
Pre Test Information	Clinical History of Patient who is going for ALG12 Gene Glycosylation disorder type 1G NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with Glycosylation disorder type 1G
Test Details	ALG12 gene glycosylation disorder type 1G is a rare genetic disorder that affects the glycosylation process in the body. Glycosylation is the process by which sugar molecules are attached to proteins and lipids, forming glycoproteins and glycolipids. This process is important for the proper functioning of many proteins in the body. The ALG12 gene provides instructions for making an enzyme called dolichyl-P-Man:Man(7)GlcNAc(2)-PP-dolichol-alpha-1,6-mannosyltransferase. This enzyme is involved in the glycosylation process, specifically the addition of mannose sugars to glycoproteins. Mutations in the ALG12 gene can disrupt the glycosylation process, leading to glycosylation disorder type 1G. This disorder can result in a wide range of symptoms, including developmental delay, intellectual disability, seizures, facial dysmorphism, and other physical abnormalities. NGS (Next-Generation Sequencing) genetic testing is a type of genetic test that uses advanced sequencing technologies to analyze multiple genes simultaneously. In the case of ALG12 gene glycosylation disorder type 1G, NGS genetic testing can be used to identify mutations or variations in the ALG12 gene that may be responsible for the disorder. By identifying these genetic variations, NGS genetic testing can provide a definitive diagnosis for individuals with suspected ALG12 gene glycosylation disorder type 1G. This can help guide medical management and treatment options for affected individuals and their families.